A Randomized Phase II Trial of 5-Day Versus 10-Day Schedules of Decitabine for Older Patients with Previously Untreated Acute Myeloid Leukemia
Year: 2017
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Blood
Authors: Nicholas J. Short, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Gautam Borthakur, Tapan M. Kadia, Xuelin Huang, Naval Daver, Courtney D. DiNardo, Alessandra Ferrajoli, William G. Wierda, Zeev Estrov, Christopher B. Benton, Prithviraj Bose, Yesid Alvarado, Steven M. Kornblau, Maro Ohanian, Yvonne Gaisor, Mary Ann Richie, Sherry Pierce, Elias Jabbour, Jorge E. Cortés, Farhad Ravandi
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2979132948